NRx Pharmaceuticals announces positive safety report for Zyesami in NIH-sponsored ACTIV-3 study in COVID-19 patients Read more
Trial reveals BPaL regimen for highly drug-resistant TB is effective even with reduced dose of linezolid Read more
Cipla, Dr Reddy’s, Emcure, Sun Pharma and Torrent to partner for clinical trial of Molnupiravir Read more
CSIR, Laxai Life Sciences get DCGI nod for clinical trials of Colchicine on COVID-19 patients Read more
SPARC declares positive results from Phase 3 clinical trial of PDP-716 to treat open-angle glaucoma or ocular hypertension Read more